HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cyclic-RGDfK peptide conjugated succinoyl-TPGS nanomicelles for targeted delivery of docetaxel to integrin receptor over-expressing angiogenic tumours.

Abstract
Docetaxel (DTX) is an anticancer drug that is used alone and in combination with other drugs to treat tumours. However, it suffers from the drawback of non-specific cytotoxicity. To improve the therapeutic potential of DTX, we report the synthesis of cRGDfK peptide-conjugated succinoyl-TPGS (tocopheryl polyethylene glycol succinate) nanomicelles for targeted delivery of DTX. Among RGD (Arg-Gly-Asp) peptides, cRGDfK peptide shows specificity towards αvβ3 integrin receptors that are most commonly over-expressed in tumour cells. To cRGDfK peptide, succinoylated TPGS was synthesised and conjugated to cRGDfK peptide using a carbodiimide reaction. Peptide-conjugated DTX loaded nanomicelles (PDNM) displayed small particle size with a narrow distribution, controlled drug release and high physicochemical stability. Cytotoxicity, cellular uptake, apoptosis and anti-angiogenic comparisons of unconjugated nanomicelles to PDNM in DU145 human prostate cancer cells and HUVECs (Human Umblical Vein Endothelial Cells) clearly revealed the importance of the cRGDfK peptide in enhancing the drug delivery performance of nanomicelles.
FROM THE CLINICAL EDITOR:
Common to many chemotherapeutic agents for cancer, systemic toxicity remains a big concern. In this article, the authors attempted to address this issue by conjugating RGD based peptides to Docetaxel, which would target integrins expressed on tumor cell surface. The experimental data revealed enhanced drug delivery.
AuthorsHitesh Kulhari, Deep Pooja, Shweta Shrivastava, Srinivasa R Telukutala, Ayan K Barui, Chitta Ranjan Patra, Ganga Modi Naidu Vegi, David J Adams, Ramakrishna Sistla
JournalNanomedicine : nanotechnology, biology, and medicine (Nanomedicine) Vol. 11 Issue 6 Pg. 1511-20 (Aug 2015) ISSN: 1549-9642 [Electronic] United States
PMID25933692 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Integrins
  • Micelles
  • Peptides, Cyclic
  • Receptors, Cell Surface
  • Taxoids
  • cyclic (arginyl-glycyl-aspartyl-phenylalanyl-lysyl)
  • Vitamin E
  • Docetaxel
  • Polyethylene Glycols
  • tocophersolan
Topics
  • Antineoplastic Agents, Phytogenic (administration & dosage)
  • Cell Line, Tumor
  • Docetaxel
  • Human Umbilical Vein Endothelial Cells
  • Humans
  • Integrins (metabolism)
  • Male
  • Micelles
  • Nanostructures
  • Neovascularization, Pathologic
  • Peptides, Cyclic (chemistry)
  • Polyethylene Glycols (chemistry)
  • Prostatic Neoplasms (blood supply, drug therapy, pathology)
  • Receptors, Cell Surface (metabolism)
  • Taxoids (administration & dosage)
  • Vitamin E (analogs & derivatives, chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: